TURN2 Trial
Cross-source consensus on TURN2 Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Other
Other
Highlighted claims
- TURN2 is a randomized, double-blind, placebo-controlled, multicentre, parallel-group phase 2 trial with an open-label extension option. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- Patients in TURN2 are allocated equally to anoxic donor FMT or anoxic autologous FMT. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- The primary objective of TURN2 is to evaluate the efficacy and safety of the augmented FMT protocol. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- Non-responders assigned to autologous FMT may receive donor FMT in an open-label extension. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- TURN2 tests whether anoxic processing, donor selection, and dual-route repetitive administration can improve FMT efficacy in mild-to-moderate active ulcerative colitis. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)